Safety and efficacy of vinorelbine in combination with pertuzumab and trastuzumab for first-line treatment of patients with HER2-positive locally advanced or metastatic breast canc...

por Perez, Edith A., López-Vega, José Manuel, Petit, Thierry, Zamagni, Claudio, Easton, Valerie, Kamber, Julia, Restuccia, Eleonora, Andersson, Michael
Publicado 2016

Efficacy and Safety of Pertuzumab and Trastuzumab Administered in a Single Infusion Bag, Followed by Vinorelbine: VELVET Cohort 2 Final Results

por Andersson, Michael, López‐Vega, José M., Petit, Thierry, Zamagni, Claudio, Easton, Valerie, Kamber, Julia, Restuccia, Eleonora, Perez, Edith A.
Publicado 2017

Real-World First-Line Use of Pertuzumab With Different Taxanes for Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: A Comparative Effectiveness Study Usi...

por Polito, Letizia, Shim, Jinjoo, Hurvitz, Sara A., Dang, Chau T., Knott, Adam, Du Toit, Yolande, Restuccia, Eleonora, Sanglier, Thibaut, Swain, Sandra M.
Publicado 2023

Impact of Dose Delays and Alternative Dosing Regimens on Pertuzumab Pharmacokinetics

por Liu, Stephanie N., Lu, Tong, Jin, Jin Y., Li, Chunze, Girish, Sandhya, Melnikov, Fjodor, Badovinac Crnjevic, Tanja, Machackova, Zuzana, Restuccia, Eleonora, Kirschbrown, Whitney P.
Publicado 2021

Pertuzumab, trastuzumab, and chemotherapy in HER2-positive gastric/gastroesophageal junction cancer: end-of-study analysis of the JACOB phase III randomized clinical trial

por Tabernero, Josep, Hoff, Paulo M., Shen, Lin, Ohtsu, Atsushi, Shah, Manish A., Siddiqui, Asna, Heeson, Sarah, Kiermaier, Astrid, Macharia, Harrison, Restuccia, Eleonora, Kang, Yoon-Koo
Publicado 2022

Pertuzumab, trastuzumab, and docetaxel for Chinese patients with previously untreated HER2-positive locally recurrent or metastatic breast cancer (PUFFIN): a phase III, randomized,...

por Xu, Binghe, Li, Wei, Zhang, Qingyuan, Shao, Zhimin, Li, Qiao, Wang, Xiaojia, Li, Huiping, Sun, Tao, Yin, Yongmei, Zheng, Hong, Feng, Jifeng, Zhang, Hong, Lei, Guiyuan, Restuccia, Eleonora
Publicado 2020

Safety and efficacy of adjuvant subcutaneous trastuzumab in human epidermal growth factor receptor 2-positive early breast cancer: Final results of the SafeHER study

por Gligorov, Joseph, Pivot, Xavier, Ataseven, Beyhan, De Laurentiis, Michelino, Jung, Kyung Hae, Manikhas, Alexey, Abdel Azim, Hamdy, Gupta, Kushagra, Alexandrou, Ari, Herraez-Baranda, Luis, Tosti, Nadia, Restuccia, Eleonora
Publicado 2022

Results of a Dose‐Finding Phase 1b Study of Subcutaneous Atezolizumab in Patients With Locally Advanced or Metastatic Non–Small Cell Lung Cancer

por Felip, Enriqueta, Burotto, Mauricio, Zvirbule, Zanete, Herraez‐Baranda, Luis A., Chanu, Pascal, Kshirsagar, Smita, Maiya, Vidya, Chan, Phyllis, Pozzi, Emanuela, Marchand, Mathilde, Monchalin, Marion, Tanaka, Kunihiko, Tosti, Nadia, Wang, Bei, Restuccia, Eleonora
Publicado 2021

Atezolizumab With Neoadjuvant Anti–Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer: Prima...

por Huober, Jens, Barrios, Carlos H., Niikura, Naoki, Jarząb, Michał, Chang, Yuan-Ching, Huggins-Puhalla, Shannon L., Pedrini, José, Zhukova, Lyudmila, Graupner, Vilma, Eiger, Daniel, Henschel, Volkmar, Gochitashvili, Nino, Lambertini, Chiara, Restuccia, Eleonora, Zhang, Hong
Publicado 2022

BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast...

por Dang, Chau, Ewer, Michael S., Delaloge, Suzette, Ferrero, Jean-Marc, Colomer, Ramon, de la Cruz-Merino, Luis, Werner, Theresa L., Dadswell, Katherine, Verrill, Mark, Eiger, Daniel, Sarkar, Sriparna, de Haas, Sanne Lysbet, Restuccia, Eleonora, Swain, Sandra M.
Publicado 2022

HER2 Copy Number and Resistance Mechanisms in Patients with HER2-positive Advanced Gastric Cancer Receiving Initial Trastuzumab-based Therapy in JACOB Trial

por Pietrantonio, Filippo, Manca, Paolo, Bellomo, Sara Erika, Corso, Simona, Raimondi, Alessandra, Berrino, Enrico, Morano, Federica, Migliore, Cristina, Niger, Monica, Castagnoli, Lorenzo, Pupa, Serenella Maria, Marchiò, Caterina, Di Bartolomeo, Maria, Restuccia, Eleonora, Lambertini, Chiara, Tabernero, Josep, Giordano, Silvia
Publicado 2023

Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study

por Kuemmel, Sherko, Tondini, Carlo A., Abraham, Jacinta, Nowecki, Zbigniew, Itrych, Bartosz, Hitre, Erika, Karaszewska, Bogusława, Juárez-Ramiro, Alejandro, Morales-Vásquez, Flavia, Pérez-García, Jose Manuel, Cardona-Huerta, Servando, Monturus, Estefania, Sequi, Marco, Restuccia, Eleonora, Benyunes, Mark, Martín, Miguel
Publicado 2021